ocal dexmedetomidine in awake fiberoptic intubatio
Not Applicable
- Conditions
- the quality of awake fiberoptic intubation.-
- Registration Number
- IRCT2015101224493N1
- Lead Sponsor
- Clinical Research Developmental Unit, Imam Hossein Medical and educational Hospital, Shahid Behesht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
18-66 year old; ASA class 1 or 2; elective surgery; probable difficult airway; probable injury to cervical spine
Exclusion criteria:
ASA >3; history of any cardiac disease; history of hypertension; history of renal function impairment; history of liver function impairment; history of opiod/recreational drug abuse; using anti hypertension drugs; usig alpha adrenergic agonists or antagonists; history of any psychological disorders; pregnancy; NPO time less than 8 hours for solid food and less than 3 hours for clear fluids; baseline heart rate less than 60 beats per minute; emergent/urgent surgeries; overt coagulopathy or impaired coagulation tests; history of diabetes mellitus
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Propofol consumption (milligrams per kilogram of body weight). Timepoint: at the time of reaching CSI score=75. Method of measurement: observation.
- Secondary Outcome Measures
Name Time Method Intubation scores. Timepoint: at the time of bronchoscopy and intubation. Method of measurement: observation.